CC chemokine ligand 2 down-modulation by selected Toll-like receptor agonist combinations contributes to T helper 1 polarization in human dendritic cells

Blood

Volumn 114, Issue 4, 2009, Pages 796-806

  Del Cornò, Manuela ^a   Michienzi, Alessandro ^a   Masotti, Andrea ^b   Da Sacco, Letizia ^b   Bottazzo, Gian Franco ^b   Belardelli, Filippo ^a   Gessani, Sandra ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; MICRORNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SYNAPTOTAGMIN I; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA; IMIDAZOLE DERIVATIVE; LIPOPOLYSACCHARIDE; MESSENGER RNA; POLYINOSINIC POLYCYTIDYLIC ACID; RESIQUIMOD; TOLL LIKE RECEPTOR;

ARTICLE; CELL POLARITY; DENDRITIC CELL; DOWN REGULATION; HUMAN; IMMUNE RESPONSE; MONOCYTE; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TH1 CELL; UPREGULATION; CELL CULTURE; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SECRETION;

CELL POLARITY; CELLS, CULTURED; CHEMOKINE CCL2; DENDRITIC CELLS; DOWN-REGULATION; DRUG COMBINATIONS; HUMANS; IMIDAZOLES; INTERFERON-BETA; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; POLY I-C; RNA, MESSENGER; TH1 CELLS; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 68249161285     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-01-199406     Document Type: Article

References (52)

1. Banchereau J, Paczesny S, Blanco P, et al. Dendritic cells: controllers of the immune system and a new promise for immunotherapy. Ann N Y Acad Sci. 2003;987:180-187. (Pubitemid 36584021)
2. Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol. 2007;7:19-30.
3. Padovan E, Landmann RM, De Libero G. How pattern recognition receptor triggering influences T cell responses: a new look into the system. Trends Immunol. 2007;28:308-314. (Pubitemid 46963137)
4. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defense. Nat Rev Immunol. 2007;7:179-190. (Pubitemid 46310482)
5. Fantuzzi L, Canini I, Belardelli F, Gessani S. HIV-1 gp120 stimulates the production of β-chemokines in human peripheral blood monocytes through a CD4-independent mechanism. J Immunol. 2001;166:5381-5387. (Pubitemid 32374157)
6. Del Cornò M, Liu QH, Schols D, et al. HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calcium-dependent, pertussis toxin-insensitive chemokine receptor signaling. Blood. 2001;98:2909-2916.
7. Colotta F, Borre A, Wang JM, et al. Expression of a monocyte chemotactic cytokine by human mononuclear phagocytes. J Immunol. 1992;148: 760-765.
8. Sylvester I, SuffrediniAF, Boujoukos AJ, et al. Neutrophil attractant protein-1 and monocyte chemoattractant protein-1 in human serum: effects of intravenous lipopolysaccharide on free attractants, specific IgG autoantibodies and immune complexes. J Immunol. 1993;151:3292-3298. (Pubitemid 23282642)
9. Van Damme J, Proost P, Put W, et al. Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers: chemical synthesis of MCP-2 and development of a specific RIA. J Immunol. 1994;152:5495-5502. (Pubitemid 24152999)
10. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci U S A. 1994;91:3652-3656. (Pubitemid 24139489)
11. Conti I, Rollins BJ. CCL2 (monocyte chemoat-tractant protein-1) and cancer. Semin Cancer Biol. 2004;14:149-154. (Pubitemid 38586739)
12. Sozzani S, Introna M, Bernasconi S, et al. MCP-1 and CCR2 in HIV infection: regulation of agonist and receptor expression. J Leukocyte Biol. 1997; 62:30-33. (Pubitemid 27321736)
13. Fantuzzi L, Spadaro F, Vallanti G, et al. Endogenous CCL2 (monocyte chemotactic protein-1) modulates human immunodeficiency virus type-1 replication and affects cytoskeleton organization in human monocyte-derived macrophages. Blood. 2003;102:2334-2337. (Pubitemid 37193566)
14. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med. 2006;354:610-621.
15. Omata N, Yasutomi M, Yamada A, Iwasaki H, Mayumi M, Ohshima Y. Monocyte chemoattractant protein-1 selectively inhibits the acquisition of CD40 ligand-dependent IL-12-producing capacity of monocyte-derived dendritic cells and modulates Th1 immune response. J Immunol. 2002; 169:4861-4866. (Pubitemid 35217149)
16. Chensue SW, Warmington KS, Ruth JH, Sanghi PS, Lincoln P, Kunkel SL. Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation, Th cell expression, and IL-12 production. J Immunol. 1996;157:4602-4608. (Pubitemid 126449382)
17. Gu L, Tseng S, Horner RM, Tam C, Loda M, Rollins BJ. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature. 2000;404:407-411. (Pubitemid 30164344)
18. Eid P, Tovey MG. Characterization of a domain of a human type I interferon receptor protein involved in ligand binding. J Interferon Cytokine Res. 1995;15:205-211.
19. Gauzzi MC, Purificato C, Donato K, et al. Suppressive effect of 1α,25-dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis. J Immunol. 2005;174:270-276. (Pubitemid 40007413)
20. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-δδCT) method. Methods. 2001; 25:402-408. (Pubitemid 34164012)
21. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19:185-193. (Pubitemid 36181903)
22. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80.
23. Chen C, Ridzon DA, Broomer AJ, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005;33:e179. (Pubitemid 41806407)
24. Jurk M, Heil F, Vollmer J, et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol. 2002;3:499. (Pubitemid 34669818)
25. Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol. 2005;6:769-776. (Pubitemid 43090462)
26. Gautier G, Humbert M, Deauvieau F, et al. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J Exp Med. 2005;201: 1435-1446. (Pubitemid 40664087)
27. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J Immunol. 2000;165: 618-622. (Pubitemid 30484724)
28. Lee J, Chuang TH, Redecke V, et al. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc Natl Acad Sci U S A. 2003;100: 6646-6651. (Pubitemid 36666635)
29. Hertzog PJ, O'Neill LA, Hamilton JA. The interferon in TLR signaling: more than just antiviral. Trends Immunol. 2003;24:534-539.
30. Akira S, Hoshino K. Myeloid differentiation factor 88-dependent and -independent pathways in Toll-like receptor signaling. J Infect Dis. 2003; 187(suppl 2):S356-S363. (Pubitemid 36724509)
31. Gauzzi MC, Canini I, Eid P, Belardelli F, Gessani S. Loss of type I IFN receptors and impaired IFN responsiveness during terminal maturation of monocyte-derived human dendritic cells. J Immunol. 2002;169:3038-3045. (Pubitemid 35013147)
32. Severa M, Remoli ME, Giacomini E, et al. Differential responsiveness to IFN-α and IFN-β of human mature DC through modulation of IFNAR expression. J Leukocyte Biol. 2006;79:1286-1294. (Pubitemid 44835564)
33. Fantuzzi L, Canini I, Belardelli F, Gessani S. IFN-β stimulates the production of β-chemokines in human peripheral blood monocytes: importance of macrophage differentiation. Eur Cytokine Netw. 2001;12:597-603. (Pubitemid 34062146)
34. Goebeler M, Gillitzer R, Kilian K, et al. Multiple signaling pathways regulate NF-κB-dependent transcription of the monocyte chemoattractant protein-1 gene in primary endothelial cells. Blood. 2001;97:46-55. (Pubitemid 32061241)
35. Ueda A, Okuda K, Ohno S, et al. NF-κB and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol. 1994;153:2052-2063. (Pubitemid 2138450)
36. Liu J. Control of protein synthesis and mRNA degradation by microRNAs. Curr Opin Cell Biol. 2008;20:214-221.
37. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. MicroRNAs: new regulators of immune cell development and function. Nat Immunol. 2008;9:839-845. (Pubitemid 352038302)
38. Schickel R, Boyerinas B, Park SM, Peter ME. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene. 2008;27:5959-5974.
39. Braun MC, Lahey E, Kelsall BL. Selective suppression of IL-12 production by chemoattractants. J Immunol. 2000;164:3009-3017. (Pubitemid 30148960)
40. Roca L, Di Paolo S, Petruzzelli V, et al. Dexamethasone modulates interleukin-12 production by inducing monocyte chemoattractant protein-1 in human dendritic cells. Immunol Cell Biol. 2007; 85:610-616. (Pubitemid 350224207)
41. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004;5:987-995. (Pubitemid 41057715)
42. Warger T, Osterloh P, Rechtsteiner G, et al. Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo. Blood. 2006;108:544-550. (Pubitemid 44061354)
43. Re F, Strominger JL. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J Immunol. 2004;173:7548-7555. (Pubitemid 39628196)
44. Bagchi A, Herrup EA, Warren HS, et al. MyD88- dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists. J Immunol. 2007;178:1164-1171. (Pubitemid 46095190)
45. Roses RE, Xu S, Xu M, Koldovsky U, Koski G, Czerniecki BJ. Differential production of IL-23 and IL-12 by myeloid-derived dendritic cells in response to TLR agonists. J Immunol. 2008;181: 5120-5127.
46. Ghosh TK, Mickelson DJ, Solberg JC, Lipson KE, Inglefield JR, Alkan SS. TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-α. Int Immunopharmacol. 2007;7:1111-1121.
47. Lu B, Rutledge BJ, Gu L, et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med. 1998;187:601-608. (Pubitemid 28093362)
48. Chensue SW, Warmington KS, Lukacs NW, et al. Monocyte chemotactic protein expression during schistosome egg granuloma formation: sequence of production, localization, contribution, and regulation. Am J Pathol. 1995;146:130-138.
49. Karpus WJ, Kennedy KJ, Kunkel SL, Lukacs NW. Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines. J Exp Med. 1998;187:733-741.
50. Gonzalo JA, Lloyd CM, Wen D, et al. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med. 1998;188:157-167. (Pubitemid 28328614)
51. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-κB-dependent induction of microRNA miR- 146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006;103:12481-12486. (Pubitemid 44267285)
52. Love TM, Moffett HF, Novina CD. Not miR-ly small RNAs: big potential for microRNAs in therapy. J Allergy Clin Immunol. 2008;121:309-319.